Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical ...

Enabled on Illumina sequencers and a new multimodal analysis platform ... Illumina’s Gold Sponsor Workshop at the Advances in Genome Biology and Technology General Meeting in Florida.

Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation ... thinking of our people and exacting analysis of our research processes.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.

being held in Florida—where the DNA sequencing giant is set to unveil more details and demonstrations—and follows up on Illumina’s recent expansions into proteomics and single-cell analysis.

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

We recently published a list of Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus. In this article, we are going to take ...

Another early user, Nick Banovich, PhD, associate professor and director, Bioinnovation and Genome ... platform, Illumina Connected Multiomics (ICM). ICM is a cloud-based multimodal analysis ...

A clear picture of Illumina's perception among financial experts is painted with a thorough analysis of recent analyst ... technology enables whole genome sequencing in humans and other large ...

"Illumina has set the standard in whole genome sequencing, and now ... 25B flow cell and DRAGEN analysis software creates a seamless end-to-end workflow enabling the high-throughput processing of ...